» Articles » PMID: 34449103

Follow-up After Breast Cancer: Variations, Best Practices, and Opportunities for Improvement According to Health Care Professionals

Overview
Publisher Wiley
Specialties Nursing
Oncology
Date 2021 Aug 27
PMID 34449103
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Follow-up after breast cancer can be divided into surveillance and aftercare. It remains unclear how follow-up can ideally be organised from the perspective of health care professionals (HCPs). The aim of this study was to gain insight in the organisation of follow-up in seven Dutch teaching hospitals and to identify best practices and opportunities for improvement of breast cancer (all stages) follow-up as proposed by HCPs.

Methods: Semi-structured in-depth group interviews were performed, one in each of the participating hospitals, with in total 16 HCPs and 2 patient advocates. To describe the organisation of follow-up, transcripts were analysed using a deductive approach. Best practices and opportunities were derived using an inductive approach.

Results: Variation was found in the organisation of aftercare, especially in timing, frequency, and disciplines of involved HCPs. Less variation was observed for surveillance, which was guided by the national guideline. Best practices focused on case management and adequate collaboration between HCPs of different disciplines. Mentioned opportunities were improving the structured monitoring of patients' needs and a comprehensive guideline for organisation and content of aftercare.

Conclusions: Variation in follow-up existed between hospitals. Shared decision-making (SDM) about surveillance is desirable to ensure that surveillance matches the patient needs, preferences, and personal risk for recurrences.

Citing Articles

The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.

van Maaren M, van Hoeve J, Korevaar J, van Hezewijk M, Siemerink E, Zeillemaker A Support Care Cancer. 2024; 32(5):323.

PMID: 38695938 PMC: 11065941. DOI: 10.1007/s00520-024-08530-2.


Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.

Klaassen-Dekker A, Drossaert C, van Maaren M, van Leeuwen-Stok A, Retel V, Korevaar J BMC Cancer. 2023; 23(1):1112.

PMID: 37964214 PMC: 10647159. DOI: 10.1186/s12885-023-11504-y.


Supporting Shared Decision-making About Surveillance After Breast Cancer With Personalized Recurrence Risk Calculations: Development of a Patient Decision Aid Using the International Patient Decision AIDS Standards Development Process in Combination....

Ankersmid J, Siesling S, Strobbe L, Meulepas J, van Riet Y, Engels N JMIR Cancer. 2022; 8(4):e38088.

PMID: 36374536 PMC: 9706380. DOI: 10.2196/38088.


Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty.

Ankersmid J, Spronk P, Zeillemaker A, Siesling S Breast Cancer Res Treat. 2022; 193(2):293-303.

PMID: 35279762 PMC: 9090881. DOI: 10.1007/s10549-022-06549-9.


Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance.

Ankersmid J, Drossaert C, van Riet Y, Strobbe L, Siesling S J Cancer Surviv. 2022; 17(5):1471-1479.

PMID: 35122224 PMC: 10442247. DOI: 10.1007/s11764-022-01178-z.


References
1.
van Hezewijk M, Smit D, Bastiaannet E, Scholten A, Ranke G, Kroep J . Feasibility of tailored follow-up for patients with early breast cancer. Breast. 2014; 23(6):852-8. DOI: 10.1016/j.breast.2014.09.002. View

2.
Elwyn G, Durand M, Song J, Aarts J, Barr P, Berger Z . A three-talk model for shared decision making: multistage consultation process. BMJ. 2017; 359:j4891. PMC: 5683042. DOI: 10.1136/bmj.j4891. View

3.
Sisler J, Chaput G, Sussman J, Ozokwelu E . Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians. Can Fam Physician. 2016; 62(10):805-811. PMC: 5063767. View

4.
Brandenbarg D, Berendsen A, de Bock G . Patients' expectations and preferences regarding cancer follow-up care. Maturitas. 2017; 105:58-63. DOI: 10.1016/j.maturitas.2017.07.001. View

5.
de Ligt K, van Egdom L, Koppert L, Siesling S, van Til J . Opportunities for personalised follow-up care among patients with breast cancer: A scoping review to identify preference-sensitive decisions. Eur J Cancer Care (Engl). 2019; 28(3):e13092. PMC: 9285605. DOI: 10.1111/ecc.13092. View